Lecture 11 - Rabies, BSE, Scrapie Flashcards
2 alt. names for Rabies virus (RABV)
Hydrofobia, Lyssa
RABIES is a
contagious viral disease of mammals, caused by Lyssavirus, characterized by central nervous system (CNS) signs and extremely high fatality.
RABIES is a contagious viral disease of mammals, caused by Lyssavirus, characterized by
central nervous system (CNS) signs and extremely high fatality.
Causative agent of rabies.
Genus and family.
Rabies virus (RABV) is a Neurotropic virus
Genus Lyssavirus,
family Rhabdoviridae
Describe Rabies strains.
Many strains – each has a particular reservoir host (e.g. skunks).
Rabies and rabies-related lyssaviruses are classified into
phylogroups.
Phylogroup I, II, III, IV.
Rabies is in phylogroup I.
Stability of RABV.
Does not survive long in the environment, not even in dried blood and secretions.
Susceptible to UV radiation.
Rapidly inactivated by sunlight and drying.
Inactivated in pH <3.0 and >11.0
Can be inactivated with many disinfectants (e.g. 45-75% ethanol).
Host range of RABV.
Reservoir hosts:
families Canidae (dogs, jackals etc), Mustelidae (e.g. skunks),
Viverridae (e.g. mongooses) and
Procyonidae (raccoons), and
the order Chiroptera (bats).
Each virus strain is maintained in a particular host. Any variant can cause rabies in other species!
NB! ZOONOSIS! All strains are zoonotic.
Morbidity of RABV.
All animals exposed to rabies do not become ill.
Humans: 20% of humans bitten by rabid dogs develop rabies.
Mortality of RABV.
(<) 100% - very high. Essentially 100% upon presentation of clinical signs.
Distribution of rabies.
worldwide
Rabies undergoes 2 epidemiological cycles:
the urban cycle
the sylvatic cycle
(sylvatic refer to wild animals)
Describe the urban cycle of rabies.
Dogs are the main reservoir host.
Predominates in areas where proportion of unvaccinated and semi-owned or stray dogs is high – Africa, Asia, the Middle East and Latin America.
Virtually eliminated in the U.S., Canada and Europe.
Describe the sylvatic cycle of rabies.
Predominant in Europe and North America.
Epidemiology is complex, affected by: viral strain, behavior of the host species, ecology and environmental factors.
Disease pattern in wildlife: relatively stable or a slow moving epidemic.
Maintenance hosts: skunks and bats, raccoons, raccoon dogs, wolves, foxes, mongooses, coyotes, jackals.
Excretion of RABV.
Via saliva.
Shedding in 50-90% of infected animals; can begin before the onset of clinical signs.
Main sources of virus: saliva and brain!
Transmission of RABV.
Direct contact: route commonly bite wounds
Aerosols – in labs or bat caves
Ingestion – experimentally infected animals
Also: mucous membranes or breaks in the skin (scratches).
IP of RABV.
less than 6 months
(dogs and cats: 2 weeks - 3 months)
In humans: few days to several years (typically 1-3 months)
Initial signs of RABV in animals.
Are nonspecific
Fearfulness, restlessness, anorexia/increased appetite, vomiting, diarrhea, slight fever, dilation of the pupils, hyperreactivity to stimuli and excessive salivation.
Behavior and temperaments changes, become unusually aggressive or uncharacteristically affectionate.
Forms of RABV. (2)
The paralytic (“dumb”) form – progressive paralysis.
- Biting is uncommon!
- Death in 2-6 days (respiratory failure)
The furious form – infection of the limbic system (more common in cats).
- drooling, attacks (fearlessness)
- Progresses to incoordination and ascending paralysis
- Death in 4-8 days after the onset of clinical signs
Clinical signs of RABV in humans.
Nonspecific prodromal signs.
Malaise, fever or headache; discomfort, pain, pruritus or other sensory alterations at the site of virus entry.
Later: insomnia, photophobia, hypersalivation, difficulty swallowing (due to laryngeal paralysis), convulsions.
Forms of RABV in humans. (2)
Encephalitic (furious) form: hyperexcitability, autonomic dysfunction and hydrophobia.
Paralytic (dumb) form: generalized paralysis.
Death in 2-10 days.
Survival extremely rare.
Post mortem lesions of RABV.
No characteristic gross lesions!
Histology of CNS:
Multifocal, mild, polioencephalomyelitis and craniospinal ganglionitis with mononuclear perivascular infiltrates, diffuse glial proliferation, regressive changes in neuronal cells, and glial nodules.
Negri bodies – aggregates of viral material in neurons.
DDx for rabies.
Any suspected mammalian encephalitis and neurological disorder must be considered in the differential diagnosis!
Canine distemper encephalitis,
Aujeszky’s disease
Toxoplasmosis
Neoplasia, trauma
Poisoning (e.g. lead)
Suspect rabies when:
behavioral changes and unexplained paralysis
Consider in all cases of unexplained neurological disease!
Material for diagnosis of RABV.
brain, saliva
Lab analyses for diagnosis of RABV.
Detecting viral antigens (immunofluorescence, immunohistochemistry, ELISA).
RT-PCR – from saliva but note, not all infected animals excrete it via the saliva! False negatives, which is why this method of testing is inadequate.
Histology – nonspecific
Serology (ELISA) – rarely used for clinical cases.
NB! Single negative test does not rule out infection! isolation in cell culture is done concurrently.
Tx of rabies.
No Tx once the clinical signs appear.
Humans: post-exposure prophylaxis – wound cleaning, administration of human rabies immunoglobulins and several doses of human rabies vaccine is highly effective if begun soon after exposure but before clinical signs appear.
Prevention of RABV.
Vaccination of domestic and wild animals, and humans.
Domestic animals: vax via injections
Wildlife: vax via ingestion
Humans: inactivated vaccines – does NOT eliminate the need for post-exposure prophylaxis but fewer treatments are needed.
Protective clothing;
careful handling of possibly rabid animals.